1,903 articles

Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance

in Cancer Molecular Targets and Therapeutics

• Ya-Wen Wang
• Xu Chen

Retraction: Corrigendum: Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/b-catenin signaling pathway activation

in Cancer Molecular Targets and Therapeutics

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates

in Cancer Molecular Targets and Therapeutics

• Heidi C. Ko
• Kyle C. Strickland
• Dana Jaggessarsingh
• Alicia Dillard
• Michelle Green
• Erin Newburn
• Tiffany Sellaro
• Jonathan L. Klein
• Brian Caveney
• Marcia Eisenberg

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

in Cancer Molecular Targets and Therapeutics

• Bowen Wang
• Mengjia Peng
• Yan Li
• Jinhang Gao
• Tao Chang

Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions

in Cancer Molecular Targets and Therapeutics

• Liqin Ruan
• Lu Wang

The efficacy and safety of 225Ac-PSMA-617 in metastatic castration-resistant prostate cancer

in Cancer Molecular Targets and Therapeutics

• Jiao Ma
• Yu Zhang
• Jiangchu Yangqing
• Guangfu Liu
• Junzheng Wang
• Chunyin Zhang

SATB2 promotes radiation resistance of esophageal squamous cell carcinoma by regulating epithelial-to-mesenchymal transition via the Wnt/β-catenin pathway

in Cancer Molecular Targets and Therapeutics

• Chen Lin
• Youyi Wu
• Yuchen Qian
• Jiayi Li
• Youdi He
• Huang Yu
• Congying Xie
• Huafang Su

Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma

in Cancer Molecular Targets and Therapeutics

• Jiro Ichikawa
• Tomonori Kawasaki
• Kojiro Onohara
• Masanori Wako
• Naofumi Taniguchi
• Satoshi Ochiai
• Hirotaka Haro

Retraction: Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/β-catenin signaling pathway activation

in Cancer Molecular Targets and Therapeutics

Emerging roles of intratumoral microbiota: a key to novel cancer therapies

in Cancer Molecular Targets and Therapeutics

• Pengzhong Fang
• Jing Yang
• Huiyun Zhang
• Diankui Shuai
• Min Li
• Lin Chen
• Liping Liu

Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review

in Cancer Molecular Targets and Therapeutics

• Wenjing Yang
• Lin Shi
• Hao Wang
• Ying Li
• Xingyu Ji
• Hongjin Li
• Guowang Yang
• Weiru Xu

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

in Cancer Molecular Targets and Therapeutics

• Yi Ding
• Qin Chen

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

in Cancer Molecular Targets and Therapeutics

• Jian-Hao Zheng
• Ding Shi
• Yun-Jie Chen
• Jian-Ping Liu
• Zheng Zhou

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

in Cancer Molecular Targets and Therapeutics

• Jiaxing Zhang
• Gang Wang
• Jie Liu
• Futian Tang
• Song Wang
• Yumin Li

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

in Cancer Molecular Targets and Therapeutics

• Hao Tian
• Qin Luo
• Liuyang Huang
• Guang Chen
• Mingsheng Sun
• Fanrong Liang

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

in Cancer Molecular Targets and Therapeutics

• Lili Wang
• Min Zhang
• Kelei Zhao
• Xiaohan Yuan
• Houyu Zhao
• Yanting Liu
• Yinghua Ji
• Ping Lu